Focus
zepbound
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
FDA Approves Mounjaro as New Obesity Drug Zepbound
The decision will makes it easier for insurance coverage for millions struggling with excess weight.